APA (7th ed.) Citation

Lemoine, M., Shimakawa, Y., Njie, R., Taal, M., Ndow, G., Chemin, I., . . . Thursz, M. R. (2016). Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. The Lancet global health, 4(8), e559-e567. https://doi.org/10.1016/S2214-109X(16)30130-9

Chicago Style (17th ed.) Citation

Lemoine, Maud, et al. "Acceptability and Feasibility of a Screen-and-treat Programme for Hepatitis B Virus Infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) Study." The Lancet Global Health 4, no. 8 (2016): e559-e567. https://doi.org/10.1016/S2214-109X(16)30130-9.

MLA (9th ed.) Citation

Lemoine, Maud, et al. "Acceptability and Feasibility of a Screen-and-treat Programme for Hepatitis B Virus Infection in The Gambia: The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) Study." The Lancet Global Health, vol. 4, no. 8, 2016, pp. e559-e567, https://doi.org/10.1016/S2214-109X(16)30130-9.